BATS BZX Real-Time Price
As of 11:41am ET
| -1.66 / -2.26%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 63.50, with a high estimate of 77.00 and a low estimate of 40.00. The median estimate represents a -11.57% decrease from the last price of 71.81.
The current consensus among 11 polled investment analysts is to Hold stock in Abiomed Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.